Filtering by:
TreatmentFDA Approves First Drug for Cancers with a High Tumor Mutational Burden
The US Food and Drug Administration (FDA) has expanded the approval of the immunotherapy drug pembrolizumab (Keytruda) to include any cancer with a high tumor mutational burden (TMB-H).
Medicare Expands Telehealth to Help Seniors Stay Home
Medicare has changed its policies to make it easier for older Americans to “see” their doctors without going in for an office visit, using their home computer or other device.
What You Should Know About Palliative Care
Palliative care is not just for end of life. It helps anyone with a serious illness manage the symptoms and stress of their condition. Learn about pain relief, emotional support, and other types of palliative care.
Caregiving Before and After Cancer Surgery
Taking care of someone who’s having cancer surgery may involve helping them get ready before the procedure, being their advocate during recovery, and then helping them get back to daily life again.
Protect Your Heart During Cancer Treatment
As cancer patients survive longer because of better treatments, they may be more likely to die of something else, including heart disease. There are often ways to help lower the risk.
FDA Approves Ayvakit (Avapritinib) for GIST
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.
FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
2019 in Review: New Cancer Drug Approvals
In 2019, the FDA approved several new drug treatments for different cancer types. Here are the stories that made headlines on cancer.org this year.
